OnePath Integra - MFS Global Balanced Equities - Managed Fund

Your data is being crunched

Fund Performance Comparison

This fund is benchmarked against the {{ }} index.

This fund's fees are: {{ mer | percentage:2 }}

Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers and {{ }}

Fee comparison

NOTE: Over the long term, higher fees lead to lower returns

{{ }} Average
Benchmark* Peers Fees InvestSMART's Fees
{{ fund.fees | percentage:2 }} N/A {{ fund.benchmark.peers.mer | percentage:2 }} {{ fund.model.mer | percentage:2 }}

* A benchmark is an arbitary calculation that does not have any fees. Hence why in the long term the majority of fund managers underperform their benchmark by the cost of their fees. InvestSMART provides low cost funds that track their benchmark.

Fund performance (31 May 2018)

NOTE : returns for periods greater than 1 year are annualised
  1 Month % 3 Month % 6 Month % 1 Year % p.a. 2 Year % p.a. 3 Year % p.a. 5 Year % p.a. 10 Year % p.a.
Total return 0.14 0.63 0.77 4.79 7.55 5.75 11.91 7.98
Growth return 0.14 0.63 0.77 4.79 7.55 5.75 11.91 7.98
Income return 0 0 0 0 0 0 0 0

Market index (MSCI World Ex Australia NR AUD)

Total return 0.37 2.58 2.17 9.8 11.55 8.13 14.9 7.92

Asset Allocation (31 May 2018)

Australian Equities 0%
International Equities 98.64%
Cash 1.36%
Property 0%
Fixed Interest 0%
Alternatives 0%
Asset Allocation

General Information

OnePath Integra - MFS Global Balanced Equities
OnePath Custodians Pty Limited
Equity World Large Growth
starstarstar (as at 31 May 2018)
Superannuation Fund
17 Dec 2005
$4.86 million (as at 31 Mar 2018)
$2.2166 (as at 21 Jun 2018)
$2.2012 (as at 21 Jun 2018)

Objectives and Strategy

The fund aims to seek capital appreciation over the longer term by investing in a diversified portfolio of global shares and aims to outperform its benchmark (the MSCI World index in AUD) over rolling 3 to 5 year periods, before taking into account fee and expenses.
Companies with sustainable above-average growth and returns, and whose prospects are not reflected in their valuation, will outperform over the long run. The value of compounding high return on capital and above-average growth rates over long time periods is often underestimated by the market.

Offer information

Standard entry fee 4%
Indirect Cost Ratio (ICR) 1.83% (as at 30 Jun 2016)
Minimum initial investment $250.00

Top 10 holdings (as at 31 Mar 2018)

Holding Type % of Portfolio
Thermo Fisher Scientific Inc Equity 3%
Login now to view the complete list of holdings.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.